The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
Open accessAbstract
BACKGROUND: The incidence of anal cancer is substantially higher among persons living with the human immunodeficiency virus (HIV) than in the general population. Similar to cervical cancer, anal cancer is preceded by high-grade squamous intraepithelial lesions (HSILs). Treatment for cervical HSIL reduces progression to cervical cancer; however, data from prospective studies of treatment for anal HSIL to prevent anal cancer are lacking. METHODS: We conducted a phase 3 trial at 25 U.S. sites. Persons living with HIV who were 35 years of age or older and who had biopsy-proven anal HSIL were randomly assigned, in a 1:1 ratio, to receive either HSIL treatment or active monitoring without treatment. Treatment included office-based ablative procedures, ablation or excision under anesthesia, or the administration of topical fluorouracil or imiquimod. The primary outcome was progression to anal cancer in a time-to-event analysis. Participants in the treatment group were treated until HSIL was completely resolved. All the participants underwent high-resolution anoscopy at least every 6 months; biopsy was also performed for suspected ongoing HSIL in the treatment group, annually in the active-monitoring group, or any time there was concern for cancer. RESULTS: Of 4459 participants who underwent randomization, 4446 (99.7%) were included in the analysis of the time to progression to cancer. With a median follow-up of 25.8 months, 9 cases were diagnosed in the treatment group (173 per 100,000 person-years; 95% confidence interval [CI], 90 to 332) and 21 cases in the active-monitoring group (402 per 100,000 person-years; 95% CI, 262 to 616). The rate of progression to anal cancer was lower in the treatment group than in the active-monitoring group by 57% (95% CI, 6 to 80; P = 0.03 by log-rank test). CONCLUSIONS: Among participants with biopsy-proven anal HSIL, the risk of anal cancer was significantly lower with treatment for anal HSIL than with active monitoring. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT02135419.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70103-7 · Cited by 1,123
Machalek, D. A., Poynten, M., Jin, F., Fairley, C. K., Farnsworth, A., Garland, S. M., Hillman, R. J., Petoumenos, K., Roberts, J., Tabrizi, S. N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70080-3 · Cited by 963
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
Palefsky, J. M., Giuliano, A. R., Goldstone, S., Moreira, E. D., Aranda, C., Jessen, H., Hillman, R., Ferris, D., Coutlee, F., Stoler, M. H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010971 · Cited by 948
Self-citationDarragh, T. M., Colgan, T. J., Thomas Cox, J., Heller, D. S., Henry, M. R., Luff, R. D., McCalmont, T., Nayar, R., Palefsky, J. M., Stoler, M. H., et al. (2013) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31826916c7 · Cited by 571
Self-citationHuman papillomavirus type distribution in anal cancer and anal intraepithelial lesions
Hoots, B. E., Palefsky, J. M., Pimenta, J. M., & Smith, J. S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24215 · Cited by 461
Self-citationBray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M., & Parkin, D. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0569 · Cited by 370
Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials
Lakatos, E. (1988) · Biometrics · doi:10.2307/2531910 · Cited by 350
Deshmukh, A. A., Suk, R., Shiels, M. S., Sonawane, K., Nyitray, A. G., Liu, Y., Gaisa, M. M., Palefsky, J. M., & Sigel, K. (2020) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz219 · Cited by 327
Self-citationAnal Cancer Incidence: Genital Warts, Anal Fissure or Fistula, Hemorrhoids, and Smoking
Holly, E. A., Whittemore, A. S., Aston, D. A., Ahn, D. K., Nickoloff, B. J., & Kristiansen, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.22.1726 · Cited by 262
Thompson, M. A., Horberg, M. A., Agwu, A. L., Colasanti, J. A., Jain, M. K., Short, W. R., Singh, T., & Aberg, J. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1391 · Cited by 256
MALIGNANT PROGRESSION OF ANAL INTRA‐EPITHELIAL NEOPLASIA
Watson, A. J. M., Smith, B. B., Whitehead, M. R., Sykes, P. H., & Frizelle, F. A. (2006) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2006.03837.x · Cited by 245
Soutter, W. P., Sasieni, P., & Panoskaltsis, T. (2006) · International Journal of Cancer · doi:10.1002/ijc.21604 · Cited by 232
Anal Cancer Risk Among People With HIV Infection in the United States
Colón-López, V., Shiels, M. S., Machin, M., Ortiz, A. P., Strickler, H., Castle, P. E., Pfeiffer, R. M., & Engels, E. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9291 · Cited by 224
Wei, F., Gaisa, M. M., D'Souza, G., Xia, N., Giuliano, A. R., Hawes, S. E., Gao, L., Cheng, S.-H., Donà, M. G., Goldstone, S. E., et al. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(21)00108-9 · Cited by 219
Self-citationBerry, J. M., Jay, N., Cranston, R. D., Darragh, T. M., Holly, E. A., Welton, M. L., & Palefsky, J. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28431 · Cited by 218
Self-citation2016 IANS International Guidelines for Practice Standards in the Detection of Anal Cancer Precursors
Hillman, R. J., Cuming, T., Darragh, T., Nathan, M., Berry-Lawthorn, M., Goldstone, S., Law, C., Palefsky, J., Barroso, L. F., Stier, E. A., et al. (2016) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000256 · Cited by 201
Self-citationMelnikow, J., McGahan, C., Sawaya, G. F., Ehlen, T., & Coldman, A. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp089 · Cited by 200
Stewart, D. B., Gaertner, W. B., Glasgow, S. C., Herzig, D. O., Feingold, D., & Steele, S. R. (2018) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001114 · Cited by 191
Richel, O., de Vries, H. J., van Noesel, C. J., Dijkgraaf, M. G., & Prins, J. M. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70067-6 · Cited by 181
Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D. A., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0060 · Cited by 157
Clarke, M. A., & Wentzensen, N. (2018) · Cancer Cytopathology · doi:10.1002/cncy.22018 · Cited by 119
Designing complex group sequential survival trials
Lakatos, E. (2002) · Statistics in Medicine · doi:10.1002/sim.1193 · Cited by 65
Goldstone, S. E., Lensing, S., Stier, E. A., Darragh, T. M., Lee, J. Y., van Zante, A., Jay, N., Berry-Lawhorn, J. M., Cranston, R., Mitsuyasu, R. T., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy615 · Cited by 65
Self-citationWhat Is the Risk of Anal Carcinoma in Patients With Anal Intraepithelial Neoplasia III?
Lee, G. C., Kunitake, H., Milch, H. N., Savitt, L. R., Stafford, C. E., Bordeianou, L., Francone, T. D., & Ricciardi, R. (2018) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001219 · Cited by 61
Palefsky, J. M., Lensing, S., Belzer, M. E., Lee, J. Y., Gaur, A. H., Mayer, K. H., Futterman, D. C., Stier, E. A., Paul, M. E., Chiao, E. Y., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab434 · Cited by 46
Self-citationGaisa, M. M., Liu, Y., Deshmukh, A. A., Stone, K., & Sigel, K. M. (2020) · Cancer · doi:10.1002/cncr.32581 · Cited by 36
Expectant Management of High-Grade Anal Dysplasia in People with HIV: Long-term Data
Cajas-Monson, L. C., Ramamoorthy, S. L., & Cosman, B. C. (2018) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001180 · Cited by 35
Shaukat, A., Shyne, M. T., Mandel, J. S., Snover, D. C., & Church, T. R. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.014 · Cited by 29
Evolution and Management of Treatment-Related Toxicity in Anal Cancer
Ludmir, E. B., Kachnic, L. A., & Czito, B. G. (2016) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2016.07.004 · Cited by 27
Lee, J. Y., Lensing, S., Berry-Lawhorn, J. M., Jay, N., Darragh, T. M., Goldstone, S. E., Wilkin, T. J., Stier, E. A., Einstein, M. H., Pugliese, J. C., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106679 · Cited by 27
Self-citationProgression of anal intraepithelial neoplasia in HIV-positive individuals: predisposing factors
McCutcheon, T., Hawkins, A. T., Muldoon, R. L., Hopkins, M. B., Geiger, T. M., & Ford, M. M. (2019) · Techniques in Coloproctology · doi:10.1007/s10151-019-01951-w · Cited by 9
Cited by
International Anal Neoplasia Society's consensus guidelines for anal cancer screening
Stier, E. A., Clarke, M. A., Deshmukh, A. A., Wentzensen, N., Liu, Y., Poynten, I. M., Cavallari, E. N., Fink, V., Barroso, L. F., Clifford, G. M., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34850 · Cited by 310
Self-citation
Metadata
- Authors
- Palefsky, J. M., Lee, J. Y., Jay, N., Goldstone, S. E., Darragh, T. M., Dunlevy, H. A., Rosa-Cunha, I., Arons, A., Pugliese, J. C., Vena, D., Sparano, J. A., Wilkin, T. J., Bucher, G., Stier, E. A., Tirado Gomez, M., Flowers, L., Barroso, L. F., Mitsuyasu, R. T., Lensing, S. Y., Logan, J., Aboulafia, D. M., Schouten, J. T., de la Ossa, J., Levine, R., Korman, J. D., Hagensee, M., Atkinson, T. M., Einstein, M. H., Cracchiolo, B. M., Wiley, D., Ellsworth, G. B., Brickman, C., & Berry-Lawhorn, J. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-06-16
- Volume
- 386
- Issue
- 24
- Pages
- 2273-2282
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4282974371
- Cited by
- 512
- References
- 32
- FWCI
- 89.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.